Oryx Bio-Tech Limited

A Leading Plasma Based Biopharmaceutical Company in Bangladesh

Oryx Bio-Tech is destined to be South Asia’s leading integrated human plasma biopharmaceutical group and the largest plasma derived products also known as Life-Saving therapeutics manufacturer in Bangladesh. The Oryx Plasma Fractionation Plant will be located on the already acquired land in the Bangabandhu Hi-Tech City at Kaliakoir, 45km from the capital city Dhaka, covering an area of 27 acres. Presently under development, the plant’s plasma processing capacity will reach 1,200 tons annually.

Our Mission

Oryx's mission is to establish and facilitate a vital connection between donor and recipient by collecting and transforming plasma.

Our Products

Human albumin Image

Human Albumin

Generally use intravenous drip or intravenous bolus. In order to prevent dehydration of the body tissue during a large number of injections, 5% dextrose injection or 0.85% sodium chloride injection may be appropriately diluted for intravenous drip.

View Details [+]
Human albumin Image

Human Fibrinogen

Pre-warm the preparation bottle containing human fibrinogen and sterilized water for injection(supplied)to 30~37℃, open the aluminum-plastic combination cap to expose the rubber stopper, and disinfect the exposed portion of the rubber stopper with a disinfectant such as alcohol.

View Details [+]
Human albumin Image

Human Immunoglobulin

Injection of immunoglobulin is a passive immunotherapy. It is to transfer a large amount of antibodies contained in the immunoglobulin to the recipient, so that it can quickly reach a temporary immune protection state from a low or no immune state.

View Details [+]

Career Opportunity

If you are a career minded, highly motivated individual and would like to join the Oryx Bio-Tech Limited. team, please send your resume and salary requirements to our Human Resources Department.

Why Oryx Bio-Tech Limited

Plasma Processing Capacity

Oryx's mission is to establish and facilitate a vital connection between donor and recipient by collecting and transforming plasma.
The group will devote itself to the research and development of new products and technologies,training, building a high-quality research team with professional and efficient research and development capabilities, and will cooperate with international research institutions.
The Group is committed to competitiveness and making high-quality medicines to improve human health.
Oryx's product line will cover three major categories, namely albumin, immunoglobulin and coagulation factors in more than 20 different specifications of plasma derived products and other biopharmaceutical products.
Pharmacists, also known as chemists or druggists, are health professionals who specialize in the use of medicines, as they deal with the composition, effects, mechanism of action and proper and effective use of drugs.
Corporate Social Responsibility has been given so many definitions; it is increasingly difficult to know what one means when invoking it. For Oryx, it is a matter of understanding that we do not exist to operate in a vacuum.
Our Standards

Achievement [at a Glance]

We believe social responsibility must be expressed pro-actively, that is, it is not enough simply to “do no harm”; we should be looking for and be aware of opportunities to do positive “good” in the world, whether it is the world of our plants and facilities, our donors and derivative users or the global environment.

  • The CFDA Standard
  • The WHO Regulations
  • The ISO 26000 Guidelines
  • The ISO 9001 Standards
  • The ISO 14001 Standards
  • The Global Compact's Ten Principles regarding human rights, labor, the environment and the fight against corruption.
Would You Like

To Donate Plasma!

Contact Us (+88) 09678-369-369